UBXN11 and glioblastoma: The addition of P-AscH− significantly augmented the cytotoxicity of SOC in classical GBM cells compared to SOC treatment alone (mean = 0.25, 0.41, respectively, p = 0.001; see Figure 1A and Figure S1A,B).